Bixiye
QP47-22 Medical Drug Management Update – Alpha-1 Proteinase Inhibitors
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1151 - 1160 ee natiijooyinka 3611
Bixiye
QP48-22 MHCP Pharmacy Benefit Exclusion for Korsuva™ and Leqvio®
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Bixiye
QP49-22 Commercial Pharmacy Benefit Exclusion for Carvykti™, Korsuva™, and Leqvio®
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Bixiye
QP50-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2022
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Bixiye
QP51-22 Blue Cross Preferred Genetic Laboratory Program
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Bixiye
QP53-22 New Operational Trends Dashboard
Taariikhda wax ku ool ah ee barnaamijka: Jun 08, 2022
Bixiye
2022 June Bulletins
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2022
Bixiye
P31R1-22 eviCore Healthcare Specialty Utilization Management (UM) Program - Laboratory Management Clinical Guideline Updates
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2022